Manuela Germeshausen practices in Hannover, Germany. Germeshausen is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Agranulocytosis, Infantile Neutropenia, and Cyclic Neutropenia.
Matthias Ballmaier practices in Hannover, Germany. Ballmaier is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. He is also highly rated in 2 other conditions, according to our data. His top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Thrombocytopenia, Bernard-Soulier Syndrome, and Agranulocytosis.
Preethi Marri is a Pediatric Hematologist Oncology specialist and a Pediatrics expert in Mobile, Alabama. Marri is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. She is also highly rated in 2 other conditions, according to our data. Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Renal Vein Thrombosis, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, and Bone Marrow Transplant. Marri is currently accepting new patients.
Summary: This phase II trial studies how well fludarabine phosphate, cyclophosphamide, total body irradiation, and donor stem cell transplant work in treating patients with blood cancer. Drugs used in chemotherapy, such as fludarabine phosphate and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them fr...
Summary: This phase II trial tests whether treosulfan, fludarabine, and rabbit antithymocyte globulin (rATG) work when given before a blood or bone marrow transplant (conditioning regimen) to cause fewer complications for patients with bone marrow failure diseases. Chemotherapy drugs, such as treosulfan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them...
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center